Patient Guide: Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 12 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06019676
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Phase: Not Specified

Where You Can Participate

This study is available at 12 locations across the country.

Top locations include:
  • • Sutton, Surrey
  • • Aylesbury,
  • • Belfast,
  • • And 9 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients - Join Clinical Trial NCTNCT06019676

How to Join This Clinical Trial - NCTNCT06019676

Learn how to participate in this Not Specified trial studying an investigational therapy for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06019676 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 12 locations. Find a study site near you:

Clinical Research Site

Sutton, Surrey SM2 5PT - United Kingdom

Status: Contact for availability

Clinical Research Site

Aylesbury, HP21 8AL - United Kingdom

Status: Contact for availability

Clinical Research Site

Belfast, BT9 7AB - United Kingdom

Status: Contact for availability

Clinical Research Site

Blackburn, BB2 3HH - United Kingdom

Status: Contact for availability

Clinical Research Site

Cambridge, CB2 0QQ - United Kingdom

Status: Contact for availability

Clinical Research Site

Cardiff, CF14 2TL - United Kingdom

Status: Contact for availability

Clinical Research Site

Lancaster, LA1 4RP - United Kingdom

Status: Contact for availability

Clinical Research Site

Liverpool, CH63 4JY - United Kingdom

Status: Contact for availability

Clinical Research Site

Middlesbrough, TS4 3BW - United Kingdom

Status: Contact for availability

Clinical Research Site

Newcastle, NE34 0PL - United Kingdom

Status: Contact for availability

And 2 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships